Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy
8-12 weeks 2 10 mL bottles 8 weeks: Uses 12 mL across the cycle
First-line obesity treatments include lifestyle intervention (e.g., low-calorie diets) and behavioral modification therapies 4,5 since approved obesity medications have limited efficacy and commonly have side effects 6
A simple consultation and, when appropriate, lab testing can clarify if injections make sense for you
One proposed advantage of AOD-9604 is that it minimally impacts insulin levels compared to full growth hormone
AOD 9604 Dosage and Protocol: What the Research Supports The standard research protocol for AOD 9604 is 300 mcg per day, administered via subcutaneous injection